Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3693523013 | Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3693525018 | Erythromycin 20 mg/g and isotretinoin 500 microgram/g cutaneous gel | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4522601000052111 | erytromycin 20 milligram/gram och isotretinoin 500 mikrogram/gram, kutan gel | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Is a | erytromycin för lokalt bruk | false | Inferred relationship | Some | ||
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Product containing isotretinoin (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has active ingredient | Erythromycin (substance) | false | Inferred relationship | Some | ||
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has active ingredient | hudläkemedel och kosmetisk produkt | false | Inferred relationship | Some | ||
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has active ingredient | Isotretinoin (substance) | false | Inferred relationship | Some | ||
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Product containing erythromycin and isotretinoin (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | kutan och/eller transdermal läkemedelsform | false | Inferred relationship | Some | ||
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | Gel | false | Inferred relationship | Some | ||
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | Cutaneous gel | true | Inferred relationship | Some | ||
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Is a | isotretinoin för lokalt bruk | false | Inferred relationship | Some | ||
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | har täljarvärde för koncentrationsstyrka | 500 | false | Inferred relationship | Some | 1 | |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | har täljarvärde för koncentrationsstyrka | 20 | false | Inferred relationship | Some | 2 | |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | har nämnarvärde som visar koncentrationsstyrka | ett | false | Inferred relationship | Some | 2 | |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | mcg | false | Inferred relationship | Some | 1 | |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has basis of strength substance (attribute) | Isotretinoin (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | räkning av bas i aktiv ingrediens | två | false | Inferred relationship | Some | ||
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 | |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | har nämnarvärde som visar koncentrationsstyrka | ett | false | Inferred relationship | Some | 1 | |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has precise active ingredient | Erythromycin (substance) | false | Inferred relationship | Some | 2 | |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has precise active ingredient | Isotretinoin (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has basis of strength substance (attribute) | Erythromycin (substance) | false | Inferred relationship | Some | 2 | |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Erythromycin and isotretinoin only product in cutaneous dose form | true | Inferred relationship | Some | ||
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some | ||
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has basis of strength substance (attribute) | Erythromycin (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has basis of strength substance (attribute) | Isotretinoin (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has precise active ingredient | Erythromycin (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has precise active ingredient | Isotretinoin (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | mcg | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets